Sunscreen TEA Advocates Want Help Scaling FDA’s ‘High Bar’ For OTC Monographs
This article was originally published in The Pink Sheet Daily
FDA explains its “high bar” for GRASE for sunscreen TEAs during a public meeting on implementation of the Sunscreen Innovation Act. Industry and advocacy groups express concern that impediments to meeting OTC monograph safety standards will squelch sunscreen ingredient innovation.
You may also be interested in...
During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.